| Patent | Date |
|---|
Methods and compositions for treating cancer
Grant 11,382,886 - Ertl , et al. July 12, 2 | 2022-07-12 |
Replication Deficient Adenoviral Vectors for HIV Vaccine Applications
App 20220211835 - Ertl; Hildegund C.J. ; et al. | 2022-07-07 |
Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same
Grant 11,291,716 - Ertl , et al. April 5, 2 | 2022-04-05 |
Constructs for enhancing immune responses
Grant 11,207,402 - Ertl , et al. December 28, 2 | 2021-12-28 |
Melanoma Canine Vaccine Compositions and Methods of Use Thereof
App 20210393757 - Ertl; Hildegund C.J. ; et al. | 2021-12-23 |
Methods And Compositions For Treating Cancer
App 20210113613 - ERTL; HILDEGUND C.J. ; et al. | 2021-04-22 |
Compositions and methods of replication deficient adenoviral vectors for vaccine applications
Grant 10,953,108 - Ertl , et al. March 23, 2 | 2021-03-23 |
Adenoviral Vectors Comprising Partial Deletions Of E3
App 20210010029 - Ertl; Hildegund C.J. ; et al. | 2021-01-14 |
Adenoviral vectors comprising partial deletions of E3
Grant 10,822,619 - Ertl , et al. November 3, 2 | 2020-11-03 |
Adenoviral Vectors Comprising Partial Deletions Of E3
App 20190360000 - ERTL; Hildegund C.J. ; et al. | 2019-11-28 |
Contructs For Enhancing Immune Responses
App 20190275143 - ERTL; Hildegund C.J. ; et al. | 2019-09-12 |
Adenoviral vectors comprising partial deletions of E3
Grant 10,407,696 - Ertl , et al. Sept | 2019-09-10 |
Contructs for enhancing immune responses
Grant 10,328,146 - Ertl , et al. | 2019-06-25 |
Compositions And Methods Of Replication Deficient Adenoviral Vectors For Vaccine Applications
App 20190167813 - ERTL; Hildegund C.J. ; et al. | 2019-06-06 |
Contructs For Enhancing Immune Responses
App 20170340730 - ERTL; Hildegund C.J. ; et al. | 2017-11-30 |
Methods for treating cancer by administration of nucleic acids encoding FAP and cancer antigens
Grant 9,744,224 - Ertl , et al. August 29, 2 | 2017-08-29 |
Constructs for enhancing immune responses
Grant 9,724,406 - Ertl , et al. August 8, 2 | 2017-08-08 |
Adenoviral Vectors Comprising Partial Deletions Of E3
App 20170175138 - ERTL; Hildegund C.J. ; et al. | 2017-06-22 |
Adenoviral vectors comprising partial deletions of E3
Grant 9,624,510 - Ertl , et al. April 18, 2 | 2017-04-18 |
Methods And Compositions For Treating Or Preventing Cancer
App 20160296612 - Ertl; Hildegund C.J. ; et al. | 2016-10-13 |
Methods and compositions for treating cancer
Grant 9,402,888 - Ertl , et al. August 2, 2 | 2016-08-02 |
Constructs For Enhancing Immune Responses
App 20150238595 - ERTL; Hildegund C.J. ; et al. | 2015-08-27 |
Constructs for enhancing immune responses
Grant 8,962,816 - Ertl , et al. February 24, 2 | 2015-02-24 |
Methods And Compositions For Treating Or Preventing Cancer
App 20140271724 - Ertl; Hildegund C. J. ; et al. | 2014-09-18 |
Adenoviral Vectors Comprising Partial Deletions Of E3
App 20140248305 - ERTL; Hildegund C. J. ; et al. | 2014-09-04 |
Universal Influenza A Vaccines
App 20130209512 - Ertl; Hildegund C. J. ; et al. | 2013-08-15 |
Constructs For Enhancing Immune Responses
App 20130028924 - ERTL; Hildegund C.J. ; et al. | 2013-01-31 |
Constructs For Enhancing Immune Responses
App 20090246220 - Ertl; Hildegund C.J. ; et al. | 2009-10-01 |
Methods for inducing an immune response via oral administration of an adenovirus
App 20060140908 - Ertl; Hildegund C. J. | 2006-06-29 |
Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
App 20020164353 - Ertl, Hildegund C. J. ; et al. | 2002-11-07 |
Method of vaccinating infants against infections
App 20010000176 - Ertl, Hildegund C. J. | 2001-04-05 |
Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
Grant 6,019,978 - Ertl , et al. February 1, 2 | 2000-02-01 |
Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
Grant 5,698,202 - Ertl , et al. December 16, 1 | 1997-12-16 |
| 